Gerben M. Franssen

Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent

Kristell L.S. Chatalic, Sandra Heskamp, Mark Konijnenberg et al. · Theranostics · 2016 · 126 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging

Miloš Petřík, Gerben M. Franssen, Hubertus Haas et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 122 citations · Full text

Medicine, Nuclear Medicine, Diagnostic Microbiology +11

PET imaging of αvβ3 integrin expression in tumours with 68Ga-labelled mono-, di- and tetrameric RGD peptides

Ingrid Dijkgraaf, Cheng‐Bin Yim, Gerben M. Franssen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 119 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

PET of Hypoxia with⁸⁹Zr-Labeled cG250-F(ab′)₂in Head and Neck Tumors

Bianca A.W. Hoeben, Johannes H.A.M. Kaanders, Gerben M. Franssen et al. · Journal of Nuclear Medicine · 2010 · 101 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts

Rafke Schoffelen, Robert M. Sharkey, David M. Goldenberg et al. · Molecular Cancer Therapeutics · 2010 · 99 citations · Full text

Medicine, Nuclear Medicine, Oncology +17